| pubmed-article:18503962 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0024128 | lld:lifeskim |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0475224 | lld:lifeskim |
| pubmed-article:18503962 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:18503962 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18503962 | pubmed:dateCreated | 2008-5-27 | lld:pubmed |
| pubmed-article:18503962 | pubmed:abstractText | Recent data strongly suggest that human leukocyte antigen (HLA) mismatching has a negative impact on development of bronchiolitis obliterans syndrome (BOS) and survival after lung transplantation (LTx). Because HLA matching is sometimes achieved by extending ischemic time in other solid-organ transplantation models and ischemic time is a risk factor per se for death after LTx, we sought to compare the theoretical benefit of HLA matching with the negative impact of lengthened ischemic time. | lld:pubmed |
| pubmed-article:18503962 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18503962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18503962 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18503962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18503962 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18503962 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:18503962 | pubmed:issn | 1557-3117 | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:PascalThomasT | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:VellyJean-Fra... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:Reynaud-Gaube... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:PisonChristop... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:SternMarcM | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:FournierMiche... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:ThabutGabriel... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:BrugièreOlivi... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:CastierYvesY | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:DromerClaireC | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:PhilippeBruno... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:MornexJean-Fr... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:DauriatGaëlle... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:Saint... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:SuberbielleCa... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:BertocchiMich... | lld:pubmed |
| pubmed-article:18503962 | pubmed:author | pubmed-author:BiondiGiusepp... | lld:pubmed |
| pubmed-article:18503962 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18503962 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:18503962 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18503962 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18503962 | pubmed:pagination | 628-34 | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:meshHeading | pubmed-meshheading:18503962... | lld:pubmed |
| pubmed-article:18503962 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18503962 | pubmed:articleTitle | Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation. | lld:pubmed |
| pubmed-article:18503962 | pubmed:affiliation | Hôpital Bichat, Paris, France. olivier.brugiere@bch.aphp.fr | lld:pubmed |
| pubmed-article:18503962 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18503962 | pubmed:publicationType | Comparative Study | lld:pubmed |
